9 results
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
algorithms by Global ... LAMA: long-acting ... muscarinic antagonist; LABA ... #Management #Pulmonary ... COPD #GOLD2017 #LAMA
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
corticosteroid; LABA ... long-acting β2-agonist; LAMA ... #Algorithm #Management ... #Pulmonary #LABA ... #LAMA #SABA #SAMA
The 2019 Global Initiative for Asthma (GINA) treatment strategy figure for adults and adolescents, annotated to
Asthma (GINA) treatment ... receptor antagonists; LABA ... #GINA #Asthma #Management ... #Stepwise #Pulmonary ... #Algorithm #Guidelines
Iatrogenic / Secondary Spontaneous Pneumothorax (SSP) Management Algorithm

Dr. Udit Chaddha @udit_chaddha

#Iatrogenic #Spontaneous #Pneumothorax #SSP #Management #Algorithm
Pneumothorax (SSP) Management ... Algorithm Dr ... #Algorithm #Treatment ... #pulmonary #PTHX ... #Thoracic
First-line therapies for Asthma, Asthma-COPD Overlap and COPD

The diagnosis of COPD, asthma, and ACO initially requires
corticosteroids; LABA ... long-acting β2-agonist; LAMA ... #Diagnosis #Management ... #Differences #Algorithm ... #Treatment
Persistent Air Leak (PAL) Management Algorithm

Persistent Air Leak = Air Leak > 5-7 days

Dr. Udit Chaddha
Air Leak (PAL) Management ... Algorithm Persistent ... PAL #Prolonged #Management ... #Algorithm #Treatment ... #Pulmonary #Thoracic
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
event, follow ACC algorithm ... Intraabdominal - Orthopedic ... Determine if any labs ... upper abdominal/thoracic ... medical and surgical management
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
with presence of pulmonary ... is vital while lab ... #differential #algorithm ... #management #cardiology ... #treatment #table
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
Ocular examination Labs ... , INC risk PE, Pulmonary ... phenomenon (16%) MSK ... Adenocarcinoma Treatment ... Rheumatology #Diagnosis #Management